BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Sep. 8, 2004
View Archived Issues
Deal With Merck Potentially Worth $26M For TransTech
TransTech Pharma Inc. secured another partnership, courtesy of its platform technology, in a collaboration that could be worth at least $26 million to the 5-year-old firm. (BioWorld Today)
Read More
MAP Series B Draws $30M For Pediatric Asthma Work
Read More
Sunesis, Biogen Idec In Cancer Deal Worth $21 Million Up Front
Read More
Vivus Launching Phase III With Female Sex Therapy
Read More
Other News To Note
Read More